Koskinas John, Deutsch Melanie, Kountouras Dimitris, Kostopanagiotou Georgia, Arkadopoulos Nikos, Smyrniotis Vasilis, Rapti Irene, Manesis Emmanuel, Archimandritis Athanasios
Second Department of Medicine, Medical School of Athens, Hippokration General Hospital, Athens, Greece.
Liver Int. 2008 Jul;28(6):821-827. doi: 10.1111/j.1478-3231.2008.01782.x. Epub 2008 May 19.
Introduction: In Western countries, the most frequent aetiology of acute liver failure (ALF) is acetaminophen overdose, while in developing countries viral infections [hepatitis A virus and hepatitis B virus (HBV)] predominate. Aim: To evaluate the epidemiology, clinical characteristics, outcome and prognostic factors of survival of patients with ALF in Greece during the last 6 years. Results: A total of 40 patients, 28 females (70%), with a median age of 37.4+/-18.6 years (range: 15-84) with ALF were studied. HBV infection was the cause in 53% of them (compared with 74% from a previous study reported in the early 1980s), drug toxicity in 15% and undetermined in 13%. The overall survival was 57.5%, including 94% with and 15% without liver transplantation. Forty-five per cent of our patients had emergency liver transplantation in European Centers within a median time of 3.3 days (1-9) from admission. The total bilirubin level at admission and the development of infections were found to be significantly associated with poor outcome. Conclusions: Hepatitis B virus still remains the most important cause of ALF in Greece, but shows a significant decrease as compared with studies in the early 1980s. Almost half of our patients needed emergency liver transplantation and had a very good survival rate. The other 15% of the patients presented spontaneous survival only with intensive medical support.
在西方国家,急性肝衰竭(ALF)最常见的病因是对乙酰氨基酚过量,而在发展中国家,病毒感染[甲型肝炎病毒和乙型肝炎病毒(HBV)]占主导地位。目的:评估希腊过去6年中ALF患者的流行病学、临床特征、结局及生存预后因素。结果:共研究了40例ALF患者,其中28例女性(70%),中位年龄为37.4±18.6岁(范围:15 - 84岁)。HBV感染是53%患者的病因(与20世纪80年代初报道的先前研究中的74%相比),药物毒性占15%,病因不明占13%。总体生存率为57.5%,其中接受肝移植的患者生存率为94%,未接受肝移植的患者生存率为15%。45%的患者在欧洲中心接受了紧急肝移植,从入院到移植的中位时间为3.3天(1 - 9天)。发现入院时总胆红素水平和感染的发生与不良结局显著相关。结论:在希腊,乙型肝炎病毒仍然是ALF的最重要病因,但与20世纪80年代初的研究相比有显著下降。几乎一半的患者需要紧急肝移植,且生存率非常高。另外15%的患者仅通过强化医疗支持实现了自发存活。